Member Exclusive News

The week in industry: Bid to outlaw off-label Avastin use rejected by UK High Court

Read our round-up of some of the breaking news from the pharmaceutical industry over the past week. This week: Novartis to cut over 2000 jobs between Switzerland and the UK and Gilead has announced plans to launch generic versions of its leading hepatitis C therapies.

Sep 27, 2018
0
0

Please sign in or register for FREE

No comments yet.